Concepedia

Xiaochen Yu

XY

Statistics

Publications

22

Citations

1.4K

H-Index

16

Active since

2014

Affiliations

Tianjin Medical University(Current)

Peking University

First Affiliated Hospital of Harbin Medical University

Harbin Medical University

Fudan University

Xiaochen Yu is an author at Tianjin Medical University specializing in pharmacology, life sciences, and medicine.

ORCID

Publications per year

2014–2023

22

Publications

22

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

Chenguang Li, Jie Zhang, Mei Xue et al. · Cardiovascular Diabetology · 2019 · 588 citations · Full text

, , +17

Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway

Xiangyang Liu, Chaofei Xu, Linxin Xu et al. · Metabolism · 2020 · 116 citations

, , +17

Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice

Mei Xue, Ting Li, Yue Wang et al. · Clinical Science · 2019 · 99 citations · Full text

, , +17

Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes

Ying Cheng, Xiaochen Yu, Jie Zhang et al. · Diabetologia · 2019 · 90 citations · Full text

, , +14

Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2–STAT3 signaling pathway

Wenzhen Dang, Hui Li, Bing‐Hua Jiang et al. · Phytomedicine · 2019 · 66 citations

, , +16

1–5 of 22